Why R&D innovation holds the key to greater patient impact
European Pharmaceutical Review
MAY 2, 2023
Clinical trials Growing internal capabilities Approximately 90 percent of the investment required to develop new medicines is the cost of conducting clinical trials. Central to this is embracing the power of strategic collaborations , through partnering with other pharmaceutical companies and academia.
99 
Let's personalize your content